Stockreport

Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson

Pulmatrix, Inc.  (PULM) 
Last pulmatrix, inc. earnings: 8/5 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.pulmatrix.com